$MOTS
Motus GI Holdings, Inc. Stock $mots

$mots Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022084 Filed on August 11, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$278.0K	$185.0K	$20.00K
YoY Change	97.16%	85.0%	-60.0%
Cost Of Revenue	$83.00K	$68.00K	$174.0K
YoY Change	27.69%	61.9%	480.0%
Gross Profit	$195.0K	$117.0K	-$154.0K
YoY Change	156.58%	101.72%	-870.0%
Gross Profit Margin	70.14%	63.24%	-770.0%
Selling, General & Admin	$3.327M	$3.297M	$3.097M
YoY Change	9.44%	5.0%	-0.74%
% of Gross Profit	1706.15%	2817.95%
Research & Development	$1.573M	$1.413M	$1.275M
YoY Change	32.52%	-6.3%	-5.56%
% of Gross Profit	806.67%	1207.69%
Depreciation & Amortization	$128.0K	$129.0K	$124.0K
YoY Change	8.47%	29.0%	24.0%
% of Gross Profit	65.64%	110.26%
Operating Expenses	$4.900M	$4.710M	$4.372M
YoY Change	15.92%	1.33%	-1.97%
Operating Profit	-$4.705M	-$4.593M	-$4.526M
YoY Change	13.35%	0.07%	1.94%
Interest Expense	$338.0K	$356.0K	-$285.0K
YoY Change	-232.55%	-334.21%	35.71%
% of Operating Profit
Other Income/Expense, Net	$0.00
YoY Change	-100.0%
Pretax Income	-$4.964M	-$5.140M	-$4.811M
YoY Change	2.9%	8.39%	3.46%
Income Tax
% Of Pretax Income
Net Earnings	-$4.964M	-$5.140M	-$4.811M
YoY Change	2.9%	8.39%	3.48%
Net Earnings / Revenue	-1785.61%	-2778.38%	-24055.0%
Basic Earnings Per Share	-$1.69	-$1.86	-$1.86
Diluted Earnings Per Share	-$1.690M	-$1.863M	-$1.858M
COMMON SHARES
Basic Shares Outstanding	2.997M shares
Diluted Shares Outstanding	183.9K shares	2.758M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.29M	$15.76M	$20.34M
YoY Change	-43.79%	-40.27%	-26.71%
Cash & Equivalents	$13.29M	$15.76M	$20.34M
Short-Term Investments
Other Short-Term Assets	$1.018M	$1.317M	$1.347M
YoY Change	92.08%	53.32%	10.41%
Inventory	$1.014M	$1.038M	$700.0K
Prepaid Expenses
Receivables	$161.0K	$81.00K	$18.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$15.49M	$18.19M	$22.40M
YoY Change	-37.75%	-35.06%	-24.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.395M	$1.329M	$2.009M
YoY Change	-36.21%	-38.56%	-1.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.00K	$13.00K	$13.00K
YoY Change	0.0%	0.0%	30.0%
Total Long-Term Assets	$1.879M	$1.889M	$2.022M
YoY Change	-14.59%	-13.19%	-1.84%
TOTAL ASSETS
Total Short-Term Assets	$15.49M	$18.19M	$22.40M
Total Long-Term Assets	$1.879M	$1.889M	$2.022M
Total Assets	$17.37M	$20.08M	$24.43M
YoY Change	-35.87%	-33.49%	-23.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.696M	$2.212M	$1.992M
YoY Change	15.36%	2.88%	-1.39%
Accrued Expenses	$248.0K	$266.0K	$296.0K
YoY Change	-17.33%	1.92%	23.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.453M	$1.757M	$1.083M
YoY Change		-77.99%	-86.43%
Total Short-Term Liabilities	$5.467M	$4.253M	$3.379M
YoY Change	106.61%	-59.11%	-67.0%
LONG-TERM LIABILITIES
Long-Term Debt	$5.251M	$5.892M	$10.36M
YoY Change	-37.68%
Other Long-Term Liabilities	$2.009M	$2.103M	$2.077M
YoY Change	-9.75%	-4.45%	-5.59%
Total Long-Term Liabilities	$5.251M	$5.892M	$12.44M
YoY Change	-50.7%	167.7%	465.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.467M	$4.253M	$3.379M
Total Long-Term Liabilities	$5.251M	$5.892M	$12.44M
Total Liabilities	$16.60M	$16.11M	$15.82M
YoY Change	24.86%	27.84%	27.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$137.7M	-$132.7M
YoY Change
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$762.0K	$3.972M	$8.606M
YoY Change
Total Liabilities & Shareholders Equity	$17.37M	$20.08M	$24.43M
YoY Change	-35.87%	-33.49%	-23.36%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$4.964M	-$5.140M	-$4.811M
YoY Change	2.9%	8.39%	3.48%
Depreciation, Depletion And Amortization	$128.0K	$129.0K	$124.0K
YoY Change	8.47%	29.0%	24.0%
Cash From Operating Activities	-$3.618M	-$4.565M	-$5.246M
YoY Change	24.33%	49.43%	15.55%
INVESTING ACTIVITIES
Capital Expenditures	-$166.0K	-$48.00K	-$1.000K
YoY Change	6.41%	-62.79%	-99.29%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$166.0K	-$48.00K	-$1.000K
YoY Change	6.41%	-62.79%	-99.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.321M	32.00K	3.022M
YoY Change	289.68%	-98.24%	-73.97%
NET CHANGE
Cash From Operating Activities	-3.618M	-4.565M	-5.246M
Cash From Investing Activities	-166.0K	-48.00K	-1.000K
Cash From Financing Activities	1.321M	32.00K	3.022M
Net Change In Cash	-2.463M	-4.581M	-2.225M
YoY Change	-9.68%	234.38%	-132.11%
FREE CASH FLOW
Cash From Operating Activities	-$3.618M	-$4.565M	-$5.246M
Capital Expenditures	-$166.0K	-$48.00K	-$1.000K
Free Cash Flow	-$3.452M	-$4.517M	-$5.245M
YoY Change	25.34%	54.37%	19.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001686850
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q2	mots	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory		usd
	mots	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory		usd
CY2022Q2	mots	Deemed Dividends From Warrant Issuance DeemedDividendsFromWarrantIssuance		usd
CY2021Q2	mots	Deemed Dividends From Warrant Issuance DeemedDividendsFromWarrantIssuance		usd
	mots	Deemed Dividends From Warrant Issuance DeemedDividendsFromWarrantIssuance		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	mots	Provision For Excess And Obsolete Inventory ProvisionForExcessAndObsoleteInventory		usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	mots	Proceeds From Issuance Of Common Shares Pursuant To Atthemarket Issuance Registered Offering ProceedsFromIssuanceOfCommonSharesPursuantToAtthemarketIssuanceRegisteredOffering		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
	mots	Prepaid In Addition On Lease Rightofuse Aset PrepaidInAdditionOnLeaseRightofuseAset		usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38389
	dei	Entity Registrant Name EntityRegistrantName	Motus GI Holdings, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-4042793
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1301 East Broward Boulevard
	dei	Entity Address Address Line2 EntityAddressAddressLine2	3rd Floor
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Lauderdale
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33301
	dei	City Area Code CityAreaCode	(954)
	dei	Local Phone Number LocalPhoneNumber	541 8000
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2996837	shares
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	MOTS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15757000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22563000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	81000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	109000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	1038000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	496000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1317000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	793000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	18193000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	23961000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1329000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1428000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	547000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13000	usd
CY2022Q2	us-gaap	Assets Assets	20082000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2212000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	266000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	18000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	270000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	271000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1757000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4253000	usd
CY2022Q2	mots	Contingent Royalty Obligation Non Current ContingentRoyaltyObligationNonCurrent	1823000	usd
CY2021Q4	mots	Contingent Royalty Obligation Non Current ContingentRoyaltyObligationNonCurrent	1760000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	280000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	385000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	138000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	166000	usd
CY2022Q2	mots	Convertible Note Noncurrent ConvertibleNoteNoncurrent	3862000	usd
CY2021Q4	mots	Convertible Note Noncurrent ConvertibleNoteNoncurrent	3834000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	221000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	317000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5750000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5750000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2765259	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2765259	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2416021	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2416021	shares
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5892000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7121000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	16110000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	16432000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	136677000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	132411000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-132705000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-122754000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3972000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9657000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20082000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26089000	usd
CY2022Q2	us-gaap	Revenues Revenues	185000	usd
CY2021Q2	us-gaap	Revenues Revenues	100000	usd
	us-gaap	Revenues Revenues	205000	usd
	us-gaap	Revenues Revenues	151000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	68000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	42000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	83000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	70000	usd
	mots	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory	159000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1413000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1508000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2688000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2853000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1222000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	795000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2205000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1471000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2075000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2345000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4189000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4789000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	4778000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	4690000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	9324000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	9183000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4593000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4590000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9119000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9032000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9951000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15536000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.86
CY2022Q2	mots	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-92000	usd
CY2021Q2	mots	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-37000	usd
	mots	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-63000	usd
	mots	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-117000	usd
CY2022Q2	mots	Finance Income Expense Net FinanceIncomeExpenseNet	-359000	usd
CY2021Q2	mots	Finance Income Expense Net FinanceIncomeExpenseNet	-117000	usd
	mots	Finance Income Expense Net FinanceIncomeExpenseNet	-691000	usd
	mots	Finance Income Expense Net FinanceIncomeExpenseNet	-234000	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-96000	usd
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-78000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-8000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5140000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-4742000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9951000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9391000	usd
	mots	Deemed Dividends From Warrant Issuance DeemedDividendsFromWarrantIssuance	6145000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5140000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4742000	usd
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.99
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.83
CY2022Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2758457	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2386633	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2674536	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2274688	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9657000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	111000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3004000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	235000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	521000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4811000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8606000	usd
CY2022Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	45000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	461000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5140000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3972000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11290000	usd
CY2021Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	366000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11593000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11593000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	272000	usd
	mots	Issuance Of Common Stock For Board Of Directors Compensation IssuanceOfCommonStockForBoardOfDirectorsCompensation	114000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	53000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	919000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-4649000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	19425000	usd
CY2021Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	74000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1826000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1826000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	19000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	53000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1010000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-4742000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	17591000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9951000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9391000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	253000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	200000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	125000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4000	usd
	mots	Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation LossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-63000	usd
	mots	Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation LossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-117000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	982000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1929000	usd
	mots	Provision For Excess And Obsolete Inventory ProvisionForExcessAndObsoleteInventory	159000	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	36000	usd
	mots	Issuance Of Common Stock For Board Of Directors Compensation IssuanceOfCommonStockForBoardOfDirectorsCompensation	118000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	175000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	54000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-28000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	764000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-43000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	407000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	366000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-459000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-204000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-177000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-57000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	8000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-53000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9811000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7595000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	269000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-49000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-269000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	34000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	11959000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1901000	usd
	mots	Proceeds From Issuance Of Common Shares Pursuant To Atthemarket Issuance Registered Offering ProceedsFromIssuanceOfCommonSharesPursuantToAtthemarketIssuanceRegisteredOffering	3165000	usd
	mots	Payments Of Financing Fees PaymentsOfFinancingFees	111000	usd
	mots	Payments Of Financing Fees PaymentsOfFinancingFees	436000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3054000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13424000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6806000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5560000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22563000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20819000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15757000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26379000	usd
	us-gaap	Interest Paid Net InterestPaidNet	511000	usd
	us-gaap	Interest Paid Net InterestPaidNet	222000	usd
	us-gaap	Stock Issued1 StockIssued1	56000	usd
	mots	Common Stock Issued For Prepaid Board Of Directors Compensation CommonStockIssuedForPrepaidBoardOfDirectorsCompensation	117000	usd
	mots	Common Stock Issued For Prepaid Board Of Directors Compensation CommonStockIssuedForPrepaidBoardOfDirectorsCompensation	121000	usd
	mots	Reclassification Of Prepaid Expenses To Fixed Assets ReclassificationOfPrepaidExpensesToFixedAssets	4000	usd
	mots	Reclassification Of Prepaid Expenses To Fixed Assets ReclassificationOfPrepaidExpensesToFixedAssets	75000	usd
	mots	Reclassification Of Inventory To Fixed Assets ReclassificationOfInventoryToFixedAssets	62000	usd
	mots	Reclassification Of Inventory To Fixed Assets ReclassificationOfInventoryToFixedAssets	56000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	75000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	73000	usd
	mots	Financing Fees Included In Accounts Payable And Accrued Expenses FinancingFeesIncludedInAccountsPayableAndAccruedExpenses	5000	usd
	mots	Financing Fees Included In Accounts Payable And Accrued Expenses FinancingFeesIncludedInAccountsPayableAndAccruedExpenses	4000	usd
	mots	Prepaid In Addition On Lease Rightofuse Aset PrepaidInAdditionOnLeaseRightofuseAset	3000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80E_eus-gaap--NatureOfOperations_zhMWb3zbaHmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_820_zB9pWhvDfzw2">Description of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motus GI Holdings, Inc. (the “Company”) was incorporated in Delaware, U.S.A. in September 2016. The Company and its subsidiaries, Motus GI Technologies, Ltd. and Motus GI, LLC, are collectively referred to as “Motus GI” or the “Company”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the “FDA”) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (“GI”) endoscopy procedures. The Pure-Vu System has received a CE Mark in the EU for use in colonoscopy. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Through irrigation and evacuation of debris, the Pure-Vu System is designed to provide better-quality exams. The Company received 510(k) clearance in February 2022 from the FDA for its Pure-Vu EVS System and recently commenced commercialization of this product.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9811000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9951000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15757000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zUurZhDbMQo5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	569000	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	68000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	670000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	292000	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	50000	usd
	us-gaap	Servicing Liability At Fair Value Description Of Other Changes In Fair Value ServicingLiabilityAtFairValueDescriptionOfOtherChangesInFairValue	The Company recalculated the fair value of the liability by applying a +/- 2% change to the input variable in the discounted cash flow model; the discount rate. A 2% decrease in the discount rate would increase the liability by $137 and a 2% increase in the discount rate would decrease the liability by $125.
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	159000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2021Q2	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	350000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	365000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	1038000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	496000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2955000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2818000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1626000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1390000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1329000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1428000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	129000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	253000	usd
CY2022Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	36000	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	36000	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	102000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	200000	usd
	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	Certain operating leases include escalation clauses and some of which may include options to extend the leases for up to 3 years.
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	23000	usd
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	32000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	62000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	64000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	30000	usd
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	30000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	60000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	60000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	53000	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	62000	usd
	us-gaap	Lease Cost LeaseCost	122000	usd
	us-gaap	Lease Cost LeaseCost	124000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	547000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	687000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	266000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	307000	usd
	mots	Loss On Change In Fair Value Of Contingent Royalty Obligation LossOnChangeInFairValueOfContingentRoyaltyObligation	117000	usd
	us-gaap	Manufacturing Costs ManufacturingCosts	285000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	1428000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	280000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	385000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	546000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	692000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M2D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y5M26D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0744	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0766	pure
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	53000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	122000	usd
CY2022Q2	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	60000	usd
	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	107000	usd
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	62000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	124000	usd
CY2021Q2	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	47000	usd
	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	94000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	540000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	535000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	125000	usd
	us-gaap	Interest Expense InterestExpense	660000	usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	291000	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	65000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	356000	usd
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	1332000	usd
CY2022Q2	mots	London Interbank Offered Rate LondonInterbankOfferedRate	1424000	usd
CY2021Q4	mots	London Interbank Offered Rate LondonInterbankOfferedRate	1419000	usd
	mots	Royalties Percentage RoyaltiesPercentage	0.04	pure
	mots	Net Sales Percentage NetSalesPercentage	0.03	pure
	mots	Licensing Percentage LicensingPercentage	0.05	pure
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	30000000	usd
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	30000000	usd
CY2022Q2	mots	Contingent Royalty Obligation Non Current ContingentRoyaltyObligationNonCurrent	1823000	usd
CY2021Q4	mots	Contingent Royalty Obligation Non Current ContingentRoyaltyObligationNonCurrent	1760000	usd
CY2022Q2	mots	Loss On Change In Fair Value Of Contingent Royalty Obligation LossOnChangeInFairValueOfContingentRoyaltyObligation	92000	usd
	mots	Loss On Change In Fair Value Of Contingent Royalty Obligation LossOnChangeInFairValueOfContingentRoyaltyObligation	63000	usd
CY2021Q2	mots	Loss On Change In Fair Value Of Contingent Royalty Obligation LossOnChangeInFairValueOfContingentRoyaltyObligation	37000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0204	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0073	pure
CY2022Q2	mots	License Fees LicenseFees	60000	usd
	mots	License Fees LicenseFees	107000	usd
CY2021Q2	mots	License Fees LicenseFees	47000	usd
	mots	License Fees LicenseFees	94000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	26000	usd
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	11000000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	394577	shares
CY2022Q2	mots	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	50.87
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	307592	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	54.10
	mots	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P7Y5M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	98747	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.98
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	75	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	36.77
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2353	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	12.17
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	403911	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	43.34
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M29D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M3D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9931	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0676	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.80
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	461000	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1010000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	982000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1929000	usd

Files In Submission

Name	View Source	Status
0001493152-22-022084-index-headers.html	Edgar Link	pending
0001493152-22-022084-index.html	Edgar Link	pending
0001493152-22-022084.txt	Edgar Link	pending
0001493152-22-022084-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mots-20220630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mots-20220630_cal.xml	Edgar Link	unprocessable
mots-20220630_def.xml	Edgar Link	unprocessable
mots-20220630_pre.xml	Edgar Link	unprocessable
mots-20220630_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOTS
Motus GI Holdings, Inc. Stock $mots

2022 Q3 Form 10-Q Financial Statement

#000149315222022084 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOTS Motus GI Holdings, Inc. Stock $mots

2022 Q3 Form 10-Q Financial Statement

#000149315222022084 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOTS
Motus GI Holdings, Inc. Stock $mots